Key Points
- CTO David Tsao sold 20,000 Billiontoone shares at an average price of $108.15, generating $2.16 million. The Rule 10b5-1 transaction reduced his direct holdings by 95.24%, to 1,000 shares.
- BLLN shares opened at $95.75, with a $4.52 billion market capitalization and a price-to-earnings ratio of 136.79. The stock has traded between $61.96 and $150.44 over the past year.
- Analysts maintain a generally positive view, with seven Buy, three Hold, and one Sell rating; the consensus is Moderate Buy with a $126.25 price target.
Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) SVP Bosch John Roderick Ten sold 2,834 shares of Billiontoone stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $105.15, for a total value of $297,995.10. Following the sale, the senior vice president directly owned 19,385 shares in the company, valued at approximately $2,038,332.75. The trade was a 12.75% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Bosch John Roderick Ten also recently made the following trade(s):
- On Thursday, September 24th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The stock was sold at an average price of $120.00, for a total value of $169,920.00.
- On Monday, September 21st, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $106.61, for a total value of $150,959.76.
- On Wednesday, September 9th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $97.54, for a total value of $138,116.64.
- On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $100.00, for a total value of $141,700.00.
- On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total value of $131,582.62.
Billiontoone Stock Performance
Shares of Billiontoone stock opened at $95.75 on Thursday. Billiontoone, Inc. has a 12 month low of $61.96 and a 12 month high of $150.44. The firm has a market capitalization of $4.52 billion and a P/E ratio of 136.79. The company has a current ratio of 11.69, a quick ratio of 11.31 and a debt-to-equity ratio of 0.17. The business has a fifty day simple moving average of $105.26 and a two-hundred day simple moving average of $100.66.
Billiontoone (NASDAQ:BLLN - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting analysts' consensus estimates of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The firm had revenue of $109.45 million for the quarter. On average, equities analysts forecast that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on BLLN shares. Zacks Research upgraded shares of Billiontoone from a "strong sell" rating to a "hold" rating in a report on Friday, October 2nd. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Billiontoone in a research report on Friday, September 18th. Wall Street Zen downgraded Billiontoone from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. BTIG Research cut their target price on Billiontoone from $142.00 to $130.00 and set a "buy" rating on the stock in a research note on Thursday, August 6th. Finally, Guggenheim raised their price target on Billiontoone from $125.00 to $128.00 and gave the company a "buy" rating in a report on Thursday, October 1st. Seven research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $126.25.
View Our Latest Stock Report on BLLN
Institutional Investors Weigh In On Billiontoone
A number of institutional investors have recently made changes to their positions in BLLN. Adams Street Partners LLC purchased a new position in shares of Billiontoone in the fourth quarter worth $140,063,000. Wasatch Advisors LP purchased a new stake in shares of Billiontoone during the first quarter valued at $29,179,000. Capital International Investors bought a new stake in Billiontoone in the 4th quarter worth about $14,568,000. Renaissance Technologies LLC purchased a new position in Billiontoone in the 1st quarter worth about $4,046,000. Finally, Emerald Advisers LLC raised its position in Billiontoone by 26.8% in the 1st quarter. Emerald Advisers LLC now owns 239,562 shares of the company's stock worth $18,911,000 after buying an additional 50,613 shares during the last quarter.
Billiontoone Company Profile
(
Get Free Report)
BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company's platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.
BillionToOne's primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
